Blue Trust’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$713 Buy
+7
New +$718 ﹤0.01% 2230
2025
Q1
– Sell
-23
Closed -$1.51K – 2517
2024
Q4
$1.51K Buy
+23
New +$1.58K ﹤0.01% 2236

Other funds holding IHE

Blue Trust's IHE Position: Q3 2026 in Review

Blue Trust opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 7 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #2230 among its holdings. This is a return to the name: Blue Trust previously reported a position in IHE as recently as Q4 2024.

Blue Trust first reported a position in IHE in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.51K in Q4 2024. 216 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Blue Trust held 7 shares of iShares US Pharmaceuticals ETF worth $713 as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new Blue Trust position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2230 holding.
  • Blue Trust first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 2 quarters since.
  • Blue Trust's iShares US Pharmaceuticals ETF position peaked at $1.51K in Q4 2024.
  • 216 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.